Seattle-based biotech firm Vedana Therapeutics has successfully closed a $46 million Series A financing round, a significant infusion of capital…
Read More

Seattle-based biotech firm Vedana Therapeutics has successfully closed a $46 million Series A financing round, a significant infusion of capital…
Read More
The pharmaceutical industry is witnessing a profound evolution in cancer treatment, driven by the escalating demand for highly targeted therapies.…
Read More
Parabilis Medicines, a promising biotechnology firm, is strategically positioning itself for a significant public market debut, announcing its intention to…
Read More
The human bone marrow is often described as the body’s "blood factory," a highly sophisticated and dynamic tissue responsible for…
Read More
Contraline, a pioneering biotechnology firm backed by Google Ventures, has successfully closed a substantial $92.5 million Series B financing round.…
Read More
The Indiana University School of Medicine has announced a significant leap forward in regenerative medicine and oncology through the development…
Read More
Los Angeles, CA – A novel drug candidate for glioblastoma, KTM-101, developed by researchers at the University of California, Los…
Read More
In a significant advancement for regenerative medicine and oncology, a multidisciplinary team of scientists from the University of Basel and…
Read More
A research team at Aalto University’s Department of Applied Physics has announced the development of a groundbreaking quantum-inspired algorithm designed…
Read More
Los Angeles, CA – In a significant development offering renewed hope in the challenging landscape of brain cancer treatment, researchers…
Read More